Pam K Mangat

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Radical Prostatectomy

Prostate Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Targeted oncology

Clinical trials (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Eddy Shih-Hsin Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Evan Pisick, Elie G Dib, Earle F Burgess, Michael Zakem, Nitin Rohatgi, Mehmet A Bilen, Raegan O'Lone, Gina N Grantham, Richard L Schilsky
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1 / 2 Mutation: Results From the TAPUR Study. JCO precision oncology 7 (2023)
Eugene R Ahn, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Hussein M Ali-Ahmad, John K Chan, Michael L Maitland, Sapna R Patel, Zachary Reese, Ani S Balmanoukian, Charles W Drescher, Rui Li, Apostolia-Maria Tsimberidou, Charles A Leath, Raegan O'Lone, Gina N Grantham, Susan Halabi, Richard L Schilsky
Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study. JCO precision oncology 7 (2023)
Eddy Shih-Hsin Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Evan Pisick, Elie G Dib, Earle F Burgess, Michael Zakem, Nitin Rohatgi, Mehmet A Bilen, Raegan O'Lone, Gina N Grantham, Richard L Schilsky
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1 / 2 Mutation: Results From the TAPUR Study. JCO precision oncology 7 (2023)
Herbert L Duvivier, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Tareq Al Baghdadi, Ajjai S Alva, Stephanie A Dublis, Timothy L Cannon, Carmen J Calfa, Rui Li, Deepti Behl, Vi K Chiu, Philip J Gold, Alissa S Marr, Kathryn F Mileham, Steven Francis Powell, Jordi Rodon Ahnert, Ramya Thota, Gina N Grantham, Abigail Gregory, Dominique C Hinshaw, Susan Halabi, Richard L Schilsky
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Pam K Mangat, Elizabeth Garrett-Mayer, Jacqueline K Perez, Richard L Schilsky
The Targeted Agent and Profiling Utilization Registry Study: A pragmatic clinical trial. Clinical trials (London, England) (2023)
Eddy Shih-Hsin Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Evan Pisick, Elie G Dib, Earle F Burgess, Michael Zakem, Nitin Rohatgi, Mehmet A Bilen, Raegan O'Lone, Gina N Grantham, Richard L Schilsky
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1 / 2 Mutation: Results From the TAPUR Study. JCO precision oncology 7 (2023)
Apar Kishor Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib, Herbert L Duvivier, Eugene R Ahn, Deepti Behl, Hossein Borghaei, Ani S Balmanoukian, Anu Gaba, Rui Li, Kwabena Osei-Boateng, Ramya Thota, Gina N Grantham, Abigail Gregory, Susan Halabi, Richard L Schilsky
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 7 (2023)
Nitin Rohatgi, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Funda Meric-Bernstam, Evan Pisick, Olatunji B Alese, Christopher M Reynolds, Ramya Thota, Gina M Vaccaro, Margaret von Mehren, Rebecca C Arend, Vi K Chiu, Herbert L Duvivier, Philip J Gold, Keely Hack, Alissa S Marr, Arthur Winer, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO precision oncology 7 (2023)
Ranju Gupta, Funda Meric-Bernstam, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Stacy D'Andre, Eugene R Ahn, Raegan O'Lone, Susan Halabi, Gina N Grantham, Richard L Schilsky
Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With <i>ERBB2</i> Amplification or <i>ERBB2/3</i> Mutations: Results From the TAPUR Study. JCO precision oncology 6 (2022)
Kelsey A Klute, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Reza Nazemzadeh, Kathleen J Yost, Herbert L Duvivier, Eugene R Ahn, Timothy L Cannon, Olatunji B Alese, John C Krauss, Ramya Thota, Carmen J Calfa, Crystal S Denlinger, Raegan O'Lone, Susan Halabi, Gina N Grantham, Richard L Schilsky
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO precision oncology 6 (2022)
Tareq Al Baghdadi, Elizabeth Garrett-Mayer, Susan Halabi, Pam K Mangat, Patricia Rich, Eugene R Ahn, Seungjean Chai, Andrew L Rygiel, Olufunlayo Osayameh, Kaitlyn R Antonelli, Samiha Islam, Suanna S Bruinooge, Richard L Schilsky
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. Targeted oncology 15 (6) (2021)